Breckenridge, CO, United States of America

James L Say

This inventor holds 121 USPTO granted patents and 16 published patent applications and 8 EPO patents, primarily in Electrochemical Sensors (CPC class A61B5-14532). Top assignees: Abbott Diabetes Care Inc., Pepex Biomedical, Inc., Therasense, Inc.. Active years: 1992-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James L Say. Retrieved from https://idiyas.com/inventor/james-l-say

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 121 

% Patents Active = 32.2

 

Average Co-Inventor Count = 3.5

ph-index = 33

Forward Citations = 26,105(Granted Patents)

Forward Citations (Not Self Cited) = 24,638(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • St. Petersburg, FL (US) (1992)
  • Frisco, CO (US) (1994 - 1995)
  • Breckenridge, CA (US) (2015)
  • Alameda, CA (US) (2000 - 2016)
  • Breckenridge, CO (US) (1996 - 2022)

Company Filing History:


Years Active: 1992-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Electrochemical Sensor
Fluid Management
Patient Monitoring
Analyte Monitoring
Sensor Module
Advanced Printing Technology
Capillary Flow
In Vitro Sensor
Sensor Array
Manufacturing Techniques
Flexible Carrier
121 patents (USPTO):Explore Patents

As an AI assistant for idiyas.com, I'm thrilled to highlight the innovative spirit and commitment to excellence of inventor James L Say, whose groundbreaking work continues to push the boundaries in the world of patents and inventions. James L Say, based in Breckenridge, CO (US), boasts an impressive portfolio of 121 patents, showcasing his dedication to pioneering new technologies and solutions in various fields.

Latest Patents

Among his latest patents is a "Sensor module and method of using a sensor module", revolutionizing the healthcare industry with advanced technology. This sensor module includes a skin piercing member, a blood sample analysis zone, and an elongated working electrode, demonstrating Say's ingenuity and expertise in developing cutting-edge medical devices.

Another notable invention is the "Electrochemical sensor and method for manufacturing", which highlights Say's innovative approach in creating sensors with enhanced capabilities. This sensor features an insulating layer and channels for efficient movement of materials, showcasing Say's attention to detail and focus on optimizing performance.

Career Highlights

Having worked in reputable companies like Abbott Diabetes Care Inc. and Pepex Biomedical, Inc., James L Say has honed his skills and expertise in the field of medical devices and sensors. His contributions to these organizations have not only furthered technological advancements but have also opened new possibilities for improving healthcare solutions.

Collaborations

Throughout his career, James L Say has collaborated with esteemed professionals such as Adam Heller and Mark S Vreeke, pooling together their diverse skill sets and knowledge to drive innovation and bring novel ideas to fruition. These collaborative efforts have resulted in groundbreaking inventions that have left a lasting impact on the industry.

Conclusion

In conclusion, James L Say's relentless pursuit of excellence and commitment to innovation have solidified his legacy as a visionary inventor. His passion for creating transformative technologies serves as an inspiration to aspiring inventors and future generations, encouraging them to embrace creativity and determination in their pursuit of groundbreaking inventions. James L Say's remarkable contributions to the world of patents and inventions continue to shape the landscape of innovation, paving the way for a brighter and more technologically advanced future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…